Reply Comment: Lacosamide for the Treatment of Refractory Status Epilepticus

Kesselheim AS , Mello MM , Studdert DM . Strategies and practices in off-label marketing of pharmaceuticals: a retrospective analysis of whisdeblower complaints. PLoS Med 2011; 8:e1000431.

Dalziel K , Round A , Stein K , Garside R , Castelnuovo E , Payne L . Do the findings of case series studies vary significantly according to methodological characteristics? Health Technol Assess 2005; 9.

International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication: conflicts of interest. February 2006. www.icmje.org (accessed 2012 Feb 10).

Kellinghaus C , Berning S , Immisch I . Intravenous lacosamide for treatment of status epilepticus. Acta Neurol Scand 2011; 123:137–41. DOI 10.1111/j.1600-0404.2010.01423.x

Höfler J , Unterberger I , Dobesberger J , Kuchukhidze G , Walser G , Trin-ka E . Intravenous lacosamide in status epilepticus and seizure clusters. Epilepsia 2011;52: e148–52.